Fundraising Fox

LexaGene Holdings

Beverly, US · British Columbia, Canada corporation

Biotech

Founders & leadership

J(
John (Jack) F ReganFounder
DM
Daryl M RebeckExecutive
JM
Jeffrey MitchellExecutive

Board

JM
Joseph M CarusoBoard director
MR
Manohar R FurtadoBoard director
TR
Thomas Richard SlezakBoard director

Reported raises · per SEC filings

Form D private placements

$11.3M disclosed across 5 rounds · 2019–2022

▶$1.6MraisedNov 2022 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • JOSEPH CARUSODirector
  • JANE SYKESDirector
  • STEVEN ARMSTRONGExecutive Officer
  • STEPHEN MASTROCOLADirector
  • THOMAS SLEZAKDirector
  • JEFFREY MITCHELLExecutive Officer
  • JOHN (JACK) REGANExecutive Officer, Director
Offering amount
$1.6M
Amount sold
$1.6M
First sale
Nov 2022
Incorporated
Corporation, British Columbia, Canada
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$5MraisedFeb 2022 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • JOSEPH CARUSODirector
  • STEVEN ARMSTRONGExecutive Officer
  • JOHN (JACK) REGANExecutive Officer, Director
  • STEPHEN MASTROCOLADirector
  • JANE SYKESDirector
  • JEFFREY MITCHELLExecutive Officer
  • THOMAS SLEZAKDirector
Offering amount
$11.5M
Amount sold
$5M
First sale
Feb 2022
Incorporated
Corporation, British Columbia, Canada
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$3.5MraisedFeb 2022 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • JANE SYKESDirector
  • JOSEPH CARUSODirector
  • STEPHEN J MASTROCOLADirector
  • JOHN (JACK) REGANExecutive Officer, Director
  • STEVEN ARMSTRONGExecutive Officer
  • JEFFREY MITCHELLExecutive Officer
  • THOMAS R SLEZAKDirector
Offering amount
$8.1M
Amount sold
$3.5M
First sale
Feb 2022
Incorporated
Corporation, British Columbia, Canada
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$998.8KraisedNov 2019 · 19 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Jeffrey MitchellExecutive Officer
  • Joseph M CarusoDirector
  • Manohar R FurtadoDirector
  • Thomas Richard SlezakDirector
  • John (Jack) F ReganExecutive Officer, Director
  • Daryl RebeckExecutive Officer, Director
Offering amount
$2.4M
Amount sold
$998.8K
First sale
Oct 2019
Incorporated
Corporation, British Columbia, Canada
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$115.2KraisedApr 2019 · 15 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Daryl M RebeckExecutive Officer, Director
  • John (Jack) F ReganExecutive Officer, Director
  • Jeffrey MitchellExecutive Officer
  • Manohar R FurtadoDirector
  • Joseph M CarusoDirector
  • Thomas Richard SlezakDirector
Offering amount
$265.8K
Amount sold
$115.2K
First sale
Mar 2019
Incorporated
Corporation, British Columbia, Canada
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

Who founded LexaGene Holdings?
LexaGene Holdings was founded by John (Jack) F Regan.
How much funding has LexaGene Holdings raised?
LexaGene Holdings has disclosed $11.3M raised across 5 rounds.
Where is LexaGene Holdings headquartered?
LexaGene Holdings is headquartered in Beverly, US.